MedPath

Clinical trial of prevention for PCI-related myocardial infarction evaluating index of microvascular resistance in stable coronary artery disease. -Effect of Fasudil, a selective Rho-kinase inhibitor

Not Applicable
Recruiting
Conditions
stable coronary artery disease
Registration Number
JPRN-UMIN000028739
Lead Sponsor
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1) severe anemia or infection, malignancy, decompensated congestive heart failure (2) previous myocardial infarction in the target vessel (3) target vessel is a donar or recipient of collateral artery (4)systolic blood pressure under 80mmHg (5)bronchial asthma or allergy for adenosin triphosphate (6) left main coronary trunk lesion or severe stenosis with contrast delay (7) severe renal or liver dysfunction (8) allergy for Fasudil

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
index of microvascular resistance
Secondary Outcome Measures
NameTimeMethod
high sensitive troponin T
© Copyright 2025. All Rights Reserved by MedPath